Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Yan-Yang Zhang, Xue-Feng Tang, Chang-Hui Du, Bin-Bing Wang, Zhen-Wang Bi & Bi-Rong Dong. (2016) Comparison of dual influenza and pneumococcal polysaccharide vaccination with influenza vaccination alone for preventing pneumonia and reducing mortality among the elderly: A meta-analysis. Human Vaccines & Immunotherapeutics 12:12, pages 3056-3064.
Read now
Read now
Rosa Prato, Francesca Fortunato & Domenico Martinelli. (2016) Pneumococcal pneumonia prevention among adults: is the herd effect of pneumococcal conjugate vaccination in children as good a way as the active immunization of the elderly?. Current Medical Research and Opinion 32:3, pages 543-545.
Read now
Read now
Ho Namkoong, Makoto Ishii, Yohei Funatsu, Yoshifumi Kimizuka, Kazuma Yagi, Takahiro Asami, Takanori Asakura, Shoji Suzuki, Testuro Kamo, Hiroshi Fujiwara, Sadatomo Tasaka, Tomoko Betsuyaku & Naoki Hasegawa. (2016) Theory and strategy for Pneumococcal vaccines in the elderly. Human Vaccines & Immunotherapeutics 12:2, pages 336-343.
Read now
Read now
Philip Eng, Lean Huat Lim, Chian Min Loo, James Alvin Low, Carol Tan, Eng Kiat Tan, Sin Yew Wong & Sajita Setia. (2014) Role of pneumococcal vaccination in prevention of pneumococcal disease among adults in Singapore. International Journal of General Medicine 7, pages 179-191.
Read now
Read now
Yiling Jiang, Aline Gauthier, Sam Keeping & Stuart Carroll. (2014) A public health and budget impact analysis of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UK. Expert Review of Pharmacoeconomics & Outcomes Research 14:6, pages 901-911.
Read now
Read now
Yiling Jiang, Aline Gauthier, Sam Keeping & Stuart Carroll. (2014) Cost–effectiveness of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UK. Expert Review of Pharmacoeconomics & Outcomes Research 14:6, pages 913-927.
Read now
Read now
David S Fedson. (2014) Preventing non bacteremic pneumococcal pneumonia in older adults. Human Vaccines & Immunotherapeutics 10:5, pages 1322-1330.
Read now
Read now
David S Fedson. (2014) Pneumococcal conjugate vaccination for older adults. Human Vaccines & Immunotherapeutics 10:1, pages 47-51.
Read now
Read now
Rosalind Hollingsworth & Raul Isturiz. (2014) Pneumococcal vaccination of older adults. Human Vaccines & Immunotherapeutics 10:1, pages 45-46.
Read now
Read now
Articles from other publishers (14)
A. M. Kostinov, A. A. Tarasova & K. V. Mashilov. (2023) Pneumococcal Vaccine in Adults with Bronchopulmonary Pathology: from Prevention to Treatment. Epidemiology and Vaccinal Prevention 22:3, pages 93-99.
Crossref
Crossref
Elisa Bongetti, Mauro S. Sandrin & William R. Mulley. (2023) Impact of pretransplant asplenia vaccination on anti‐A/B antibody titers in prospective ABO incompatible kidney transplant recipients. Rheumatology & Autoimmunity 3:1, pages 26-34.
Crossref
Crossref
Jan Olbrecht, Jorge A. Gomez, Laure-Anne Van Bellinghen, Ilse Van Vlaenderen & Baudouin Standaert. (2021) Constrained Optimization for Pneumococcal Vaccination in Brazil. Value in Health Regional Issues 26, pages 40-49.
Crossref
Crossref
Cynthia Rocha Dullius, Luciana Zani & José Miguel Chatkin. (2018) Theoretical pneumococcal vaccine coverage: analysis of serotypes isolated from inpatients at a tertiary care hospital. Jornal Brasileiro de Pneumologia 44:5, pages 361-366.
Crossref
Crossref
Gyu-Lee Kim, Seung-Han Seon & Dong-Kwon Rhee. (2017) Pneumonia and Streptococcus pneumoniae vaccine. Archives of Pharmacal Research 40:8, pages 885-893.
Crossref
Crossref
Stefan M.T. Vestjens, Gertjan H.J. Wagenvoort, Jan C. Grutters, Bob Meek, Arnoud F. Aldenkamp, Bart J.M. Vlaminckx, Willem Jan W. Bos, Ger T. Rijkers & Ewoudt M.W. van de Garde. (2017) Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands. Vaccine 35:33, pages 4112-4118.
Crossref
Crossref
Gal Tsaban & Shalom Ben-Shimol. (2017) Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature. Vaccine 35:22, pages 2882-2891.
Crossref
Crossref
Gertjan H.J. Wagenvoort, Elisabeth A.M. Sanders, Hester E. de Melker, Arie van der Ende, Bart J. Vlaminckx & Mirjam J. Knol. (2017) Long-term mortality after IPD and bacteremic versus non-bacteremic pneumococcal pneumonia. Vaccine 35:14, pages 1749-1757.
Crossref
Crossref
A. D. Protasov, M. P. Kostinov, A. V. Zhestkov, M. L. Shteiner, O. O. Magarshak, T. A. Kostinova, A. A. Ryzhov, D. V. Pakhomov, D. A. Blagovidov & M. I. Panina. (2016) Choice of optimal vaccination tactics against pneumococcal infection from immunological and clinical standpoints in patients with chronic obstructive pulmonary disease. Terapevticheskii arkhiv 88:5, pages 62.
Crossref
Crossref
Susanna Esposito & Nicola Principi. (2015) Pneumococcal vaccines and the prevention of community-acquired pneumonia. Pulmonary Pharmacology & Therapeutics 32, pages 124-129.
Crossref
Crossref
Anneke Steens, Didrik F. Vestrheim & Birgitte Freiesleben de Blasio. (2015) Pneumococcal vaccination in older adults in the era of childhood vaccination: Public health insights from a Norwegian statistical prediction study. Epidemics 11, pages 24-31.
Crossref
Crossref
Faye J. Lima, Deborah Lehmann, Aoiffe McLoughlin, Catherine Harrison, Judith Willis, Carolien Giele, Anthony D. Keil & Hannah C. Moore. (2014) Risk factors and comorbidities for invasive pneumococcal disease in Western Australian Aboriginal and non-Aboriginal people. Pneumonia 4:1, pages 24-34.
Crossref
Crossref
Yazeed A. Al-Sherikh, Lakshmana K. Gowda, M. Marie Mohammed Ali, James John, Dabwan Khaled Homoud Mohammed & Pradeep Chikkabidare Shashidhar. (2014) Distribution of Serotypes and Antibiotic Susceptibility Patterns Among Invasive Pneumococcal Diseases in Saudi Arabia. Annals of Laboratory Medicine 34:3, pages 210-215.
Crossref
Crossref
Gili Regev-Yochay, Galia Rahav, Klaris Riesenberg, Yonit Wiener-Well, Jacob Strahilevitz, Michal Stein, Daniel Glikman, Gabriel Weber, Israel Potasman & Ron Dagan. (2014) Initial Effects of the National PCV7 Childhood Immunization Program on Adult Invasive Pneumococcal Disease in Israel. PLoS ONE 9:2, pages e88406.
Crossref
Crossref